IL4 Gene Variants rs2243250 and rs2243248 and Their Association with Clinical Phenotypes of Severe Asthma in the Mexican Population: In Silico Functional Analysis and Regulatory Implications
Authors:
- Ingrid Berenice Montoya-DelgadoIngrid Berenice Montoya-Delgado
- Itzel Vianey Ochoa-GarcíaIOItzel Vianey Ochoa-García
- Zaira Lorena Escobedo-SalcedoZEZaira Lorena Escobedo-Salcedo
- Margarita Ortega-CisnerosMOMargarita Ortega-Cisneros
- Alicia Del Toro-ArreolaATAlicia Del Toro-Arreola
- Adrián Daneri-NavarroADAdrián Daneri-Navarro
- Yeminia ValleYVYeminia Valle
- María Enriqueta Nuñez-NuñezMNMaría Enriqueta Nuñez-Nuñez
- Beatriz Bayardo-GutierrezBBBeatriz Bayardo-Gutierrez
- Antonio Quintero-RamosAntonio Quintero-Ramos
Preprint
- 8 May 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Severe asthma (SA) is a chronic respiratory disease characterized by clinical heterogeneity and poor therapeutic response. Variants in the IL4 gene, including rs2243250 and rs2243248, have been associated with asthma susceptibility and severity in different populations; however, their role in the Mexican population remains unclear. This study evaluated the association of IL4 promoter variants rs2243250 and rs2243248 with severe asthma and its clinical characteristics in a Mexican population using genetic and in silico approaches. A total of 106 patients with SA and 180 healthy individuals were included. Genotyping was performed using allelic discrimination assays with TaqMan® probes, and associations between genotypes and clinical variables were assessed. No significant differences in allele or genotype frequencies were observed between groups. However, the rs2243250 TT genotype was associated with nocturnal symptoms (OR = 3.03, 95% CI = 1.31–7.00, p = 0.009) and increased use of rescue medication (OR = 3.16, 95% CI = 1.41–7.07, p = 0.005). The rs2243248 TG/GG genotypes were associated with epithelial allergy (p < 0.05). In silico analysis suggested a regulatory role for both variants. These findings suggest that IL4 variants may not influence overall disease risk but could modulate clinical features of asthma severity.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma BiologicsThe Journal of Allergy and Clinical Immunology: In Practice, 2024
- Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2023
- Gene–environment interactions and their impact on human healthGenes & Immunity, 2022
- Epigenetic regulation of immune function in asthmaJournal of Allergy and Clinical Immunology, 2022
- Advances in asthma: New understandings of asthma’s natural history, risk factors, underlying mechanisms, and clinical managementJournal of Allergy and Clinical Immunology, 2021
- Association of IL-4 rs2243250 polymorphism with susceptibility to tuberculosis: A meta-analysis involving 6794 subjectsMicrobial Pathogenesis, 2021
- New Targeted Therapies for Uncontrolled AsthmaThe Journal of Allergy and Clinical Immunology: In Practice, 2019
- Epidemiology and risk factors for asthmaRespiratory Medicine, 2019
- Glucocorticoid receptor expression on circulating leukocytes differs between healthy male and female adultsJournal of Clinical and Translational Science, 2017
- A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn)Cell Research, 2009